| Company Name: |
Sigma-Aldrich
|
| Tel: |
021-61415566 800-8193336 |
| Email: |
orderCN@merckgroup.com |
| Products Intro: |
Product Name:Olanzapine-d8
CAS:1093380-13-2
Purity:100 mug/mL in acetonitrile, ampule of 1 mL, certified refere Package:1ML Remarks:O-035-1ML
|
| Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
| Tel: |
13636370518 |
| Email: |
shyysw007@163.com |
| Products Intro: |
Product Name:Olanzapine-d8
CAS:1093380-13-2
Purity:100μg/ml in methanol Package:1.2ml Remarks:B28799
|
| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 400-920-5774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:Olanzapine-d8
CAS:1093380-13-2
Purity:>98% Package:1mg;10mg;50mg;100mg;
|
- Olanzapine-D8
-
- $911.00
-
2026-05-11
- CAS:1093380-13-2
- Purity:
- Supply Ability: 10g
|
| | Olanzapine-d8 Basic information |
| Product Name: | Olanzapine-d8 | | Synonyms: | Olanzapine-d8;Olanzapine-D8 solution;2-Methyl-4-(4-methyl-1-piperazinyl-2,2,3,3,5,5,6,6-d8)-10H-thieno[2,3-b][1,5]benzodiazepine;2-methyl-4-(4-methylpiperazin-1-yl-2,2,3,3,5,5,6,6-d8)-10H-benzo[b]thieno[2,3-e][1,4]diazepine;2H8]-Olanzapine;D8-Olanzapine | | CAS: | 1093380-13-2 | | MF: | C17H12D8N4S | | MW: | 320.48 | | EINECS: | | | Product Categories: | | | Mol File: | 1093380-13-2.mol |  |
| | Olanzapine-d8 Chemical Properties |
| Boiling point | 476.035±55.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.324±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | Fp | 2 °C | | storage temp. | -20°C | | solubility | DMF: 20 mg/ml; DMSO: 16 mg/ml; Ethanol: 1 mg/ml | | form | A solid | | pka | 8.153±0.20(predicted) |
| | Olanzapine-d8 Usage And Synthesis |
| Uses | Olanzapine - d8 has been considered to be used for treating chizophrenia, bipolar disorder, and psychotic depression. | | General Description | An internal standard for use in LC/MS or GC/MS applications including clinical toxicology analysis, therapeutic drug monitoring, or isotope dilution methods. Marketed under the trade name Zyprexa, olanzapine is an atypical antipsychotic drug used in the treatment of schizophrenia and bipolar disorder. | | in vivo | Olanzapine (0.75, 1.5 and 3 mg/kg) evaluates body weight and periuterine fat mass, as well as insulin, non-esterified fatty acids, triglycerides, and glucose levels in mice[6] |
| | Olanzapine-d8 Preparation Products And Raw materials |
|